Body dysmorphic disorder (BDD) affects both adults and children, with symptoms usually appearing in adolescence or early adulthood. The older term for BDD is dysmorphophobia, which is sometimes still used. It is also referred to as “imagined ugliness syndrome”, however, this term is considered trivializing to people with BDD.
The Diagnostic and Statistical Manual of Disorders is the tool used to diagnose mental disorder in the US. The DSM-IV-TR (fourth edition, text revision) is the most current version and contains criteria for BDD. However, BDD is also usually included on the obsessive-compulsive spectrum, a hypothesized family of disorders that share features with OCD.
People with BDD are preoccupied with either a completely imagined defect, or a slight anomaly in appearance. Where there is a slight defect present, the person with BDD will have excessive concerns about it.
Any body part can be of concern to someone with BDD, and in many cases the person with BDD will perceive several defects. Common perceived defects are usually facial, such as concerns about the texture of one’s skin or the shape of one’s nose.
Many people with BDD perform rituals surrounding the perceived defect. Examples include:
People with BDD often struggle with relationships and are likely to experience difficulties in socializing, working and/or other life areas. In some cases, people with BDD feel unable to leave their homes.
In order to make a diagnosis of BDD using the DSM-IV-TR, the following conditions must be satisfied:
BDD is currently classified as a somatoform disorder. Where there is poorer insight, i.e. the person is convinced their perception is accurate, the case of BDD is classified as a delusional disorder. BDD is frequently comorbid with other disorders such as major depression. People with both BDD and major depression are at increased risk of suicide.
BDD often goes undiagnosed. People with symptoms of BDD are often inhibited about coming forward due to feelings of shame and/or embarrassment. In particular, they may be worried about being labelled vain and/or narcissistic. It is more likely to be diagnosed when the physician asks specific questions relating to BDD.
Studies suggest that 1-2% of the US population has BDD, however, this figure cannot consider the cases that go undiagnosed. There is also little data available in other countries to estimate BDD’s prevalence on an international level. The available data suggests no gender differential in cases of BDD.
For more information, check out this playlist from Detox of South Florida.
Dr. Vikram Tarugu, M.D, is the CEO of Detox of South Florida, Inc and medical professional focused on addiction. A veteran in the medical field with over 25 years of professional experience. He is a consultant for many South Florida Rehab centers. Patients travel from allover the US to seek his help with addiction and Hepatitis C treatment.
© Copyright 2020, Detox of South Florida Inc. | All Rights Reserved.